UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion

Nature communications, 2024-09, Vol.15 (1), p.8309-17, Article 8309

2024

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

Bone marrow transplantation (Basingstoke), 2014-11, Vol.49 (11), p.1360-1365

2014

Volltextzugriff (PDF)

CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies

Clinical pharmacology and therapeutics, 2016-09, Vol.100 (3), p.252-258

2016

Volltextzugriff (PDF)

Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

Leukemia, 2016-02, Vol.30 (2), p.492-500

2016

Volltextzugriff (PDF)

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

Journal of clinical oncology, 1997-10, Vol.15 (10), p.3266-3274

1997

Volltextzugriff (PDF)

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-06, Vol.37 (11), p.1031-1035

2006

Volltextzugriff (PDF)

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

Leukemia, 2006-01, Vol.20 (1), p.128-135

2006

Volltextzugriff (PDF)

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab

Journal of clinical oncology, 1999-06, Vol.17 (6), p.1851-1857

1999

Volltextzugriff (PDF)

Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil

Journal of clinical pharmacology, 2013-04, Vol.53 (4), p.393-402

2013

Volltextzugriff (PDF)

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3135-3143

2000

Volltextzugriff (PDF)

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Annals of oncology, 2010-06, Vol.21 (6), p.1196-1202

2010

Volltextzugriff (PDF)

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3270-3278

1998

Volltextzugriff (PDF)

Is oxygen a friend or foe in the peri‐operative period?

Anaesthesia, 2013-05, Vol.68 (5), p.537-537

2013

Volltextzugriff (PDF)

Preclinical and phase I and II trials of rituximab

Seminars in oncology, 1999-10, Vol.26 (5), p.74-78

MALONEY, D. G

1999

Volltextzugriff (PDF)

Can the ‘two‐bag test’ detect leaks?

Anaesthesia, 2013-05, Vol.68 (5), p.536-537

2013

Volltextzugriff (PDF)

IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

Blood, 1997-09, Vol.90 (6), p.2188-2195

1997

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.804-809

2012

Volltextzugriff (PDF)

Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML

Leukemia, 2005-06, Vol.19 (6), p.990-997

2005

Volltextzugriff (PDF)

Allogeneic peripheral blood stem cell graft composition affects early T‐cell chimaerism and later clinical outcomes after non‐myeloablative conditioning

British journal of haematology, 2005-03, Vol.128 (5), p.659-667

2005

Volltextzugriff (PDF)

Evaluation of airway equipment: man or manikin?

Anaesthesia, 2011-06, Vol.66 (6), p.527-528

2011

Volltextzugriff (PDF)

An algorithm for suboptimally placed supraglottic airway devices: the choice of videolaryngoscope

British journal of anaesthesia : BJA, 2017-10, Vol.119 (4), p.843-843

2017

Volltextzugriff (PDF)

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (3), p.337-346

2004

Volltextzugriff (PDF)

Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma

Annals of oncology, 2015-11, Vol.26 (11), p.2323-2328

2015

Volltextzugriff (PDF)

The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma

Bone marrow transplantation (Basingstoke), 2007-12, Vol.40 (11), p.1039-1044

2007

Volltextzugriff (PDF)

HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL

Hematological oncology, 2023-06, Vol.41 (S2), p.87-88

2023

Volltextzugriff (PDF)

1 – 25 von 1.126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(967)
Mit Volltextzugriff
(899)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.114)
Französisch
(5)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies

Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab

Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

Is oxygen a friend or foe in the peri‐operative period?

Preclinical and phase I and II trials of rituximab

Can the ‘two‐bag test’ detect leaks?

IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy

Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML

Allogeneic peripheral blood stem cell graft composition affects early T‐cell chimaerism and later clinical outcomes after non‐myeloablative conditioning

Evaluation of airway equipment: man or manikin?

An algorithm for suboptimally placed supraglottic airway devices: the choice of videolaryngoscope

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation

Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma

The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma

HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL

Suchergebnisse filtern